All lobbying filings

CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS

Lobbying for NOVARTIS · Bio-pharmaceutical company

Filing Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 16, 2026

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 3

Executive Office of the President (EOP)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Bills named in this filing 1

HR 1672
Maintaining Investments in New Innovation Act

Lobbying activity 2

Health Issues

Support for: H.R. 1672 - Maintaining Investments in New Innovation Act (MINI Act)

Medicare/Medicaid

Issues related to the pharmaceutical industry

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.